Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.150 | 3.150 | 0.000 |
Shares | 96.730 | 96.730 | 0.000 |
Other | 0.120 | 0.120 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.928 | 23.736 |
Price to Book | 3.516 | 4.777 |
Price to Sales | 2.801 | 3.590 |
Price to Cash Flow | 14.365 | 16.579 |
Dividend Yield | 1.624 | 1.231 |
5 Years Earnings Growth | 14.148 | 12.593 |
Name | Net % | Category Average |
---|---|---|
Technology | 22.510 | 28.817 |
Healthcare | 16.550 | 14.679 |
Consumer Cyclical | 12.600 | 12.506 |
Financial Services | 12.560 | 14.057 |
Industrials | 11.900 | 12.047 |
Communication Services | 11.130 | 8.889 |
Basic Materials | 4.320 | 3.779 |
Consumer Defensive | 4.300 | 6.472 |
Energy | 2.700 | 2.639 |
Utilities | 0.980 | 2.320 |
Real Estate | 0.450 | 1.857 |
Number of long holdings: 255
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Meta Platforms | US30303M1027 | 3.78 | 647.49 | +1.73% | |
Microsoft | US5949181045 | 3.26 | 444.06 | -0.59% | |
Taiwan Semicon | TW0002330008 | 3.23 | 1,135.00 | +1.34% | |
Broadcom | US11135F1012 | 2.79 | 244.70 | +1.84% | |
Novo Nordisk B | DK0062498333 | 2.50 | 622.4 | +7.13% | |
NVIDIA | US67066G1040 | 2.24 | 142.62 | -3.12% | |
Tesla | US88160R1014 | 1.96 | 406.58 | -1.41% | |
AstraZeneca | GB0009895292 | 1.58 | 11,050.0 | +0.04% | |
Eli Lilly | US5324571083 | 1.51 | 785.41 | +2.45% | |
Netflix | US64110L1061 | 1.41 | 977.59 | -0.74% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CapGroup NewPerspectiveLux Cadh AUD | 16.67B | 19.66 | 3.77 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review